Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.

NCT04069689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome

Interventions

DRUG: EPX-100 (Clemizole Hydrochloride)
DRUG: Placebos

Sponsor

Epygenix